January 22, 2018
Via EDGAR
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549-3628
|
| | |
| Attention: | | Christine Torney |
| | | Jim Rosenberg |
| | | Chris Edwards |
| | | Erin Jaskot |
|
| | |
| Re: | | Menlo Therapeutics Inc. (the “Company”) |
| | | Registration Statement on Form S-1 (File No. 333-222324) |
| | | initially filed on January 19, 2018 |
Ladies and Gentlemen:
We hereby join the Company in requesting withdrawal of our previous request for acceleration of the above-referenced Registration Statement, which was dated January 19, 2018. The undersigned hereby confirm that we are aware of our responsibilities under the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended, as they related to the proposed public offering of Common Stock of the Company specified in the above-referenced Registration Statement.
(Signature page follows)
|
|
| Very truly yours, |
| |
| JEFFERIES LLC |
| PIPER JAFFRAY & CO |
| GUGGENHEIM SECURITIES, LLC |
| As representatives of the several underwriters |
|
| |
| By: | JEFFERIES LLC. |
| | |
| By: | /s/Michael Brinkman |
| Name: | Michael Brinkman |
| Title: | Managing Director |
|
| |
| By: | PIPER JAFFRAY & CO. |
| | |
| By: | /s/Christie L. Christina |
| Name: | Christie L. Christina |
| Title: | Managing Director |
|
| |
| By: | GUGGENHEIM SECURITIES, LLC |
| | |
| By: | /s/Shiv Taylor |
| Name: | Shiv Taylor |
| Title: | Managing Director |
Signature Page to Acceleration Request Letter Withdrawal
